SG Americas Securities
HLVX

SG Americas Securities’s HilleVax HLVX Stock Holding History

SG Americas Securities’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,034
Closed -$15K – 3222
2025
Q1 		$15K Sell
10,034
-8,111
-45% -$15K ﹤0.01% 3395
2024
Q4 		$38K Buy
18,145
+6,916
+62% +$13K ﹤0.01% 2953
2024
Q3 		$20K Buy
+11,229
New +$28.8K ﹤0.01% 3346
2024
Q2 		– Sell
-7,621
Closed -$127K – 3042
2024
Q1 		$127K Sell
7,621
-1,065
-12% -$17K ﹤0.01% 2355
2023
Q4 		$139K Buy
+8,686
New +$115K ﹤0.01% 2487

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SG Americas Securities's HLVX Position: Q2 2025 in Review

SG Americas Securities sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 10,034 shares — an estimated $15K sold.

SG Americas Securities first reported a position in HLVX in Q4 2023 and held it in 5 quarters. The position peaked at $139K in Q4 2023. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • SG Americas Securities reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 10,034 HilleVax shares in Q2 2025, an estimated $15K.
  • SG Americas Securities first reported a position in HilleVax in Q4 2023 and held it in 5 quarters.
  • SG Americas Securities's HilleVax position peaked at $139K in Q4 2023.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.